Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
Article
PubMed
Google Scholar
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
Article
PubMed
Google Scholar
Chaney SG, Campbell SL, Bassett E, Wu Y. Recognition and processing of cisplatin- and oxaliplatin-DNA adducts. Crit Rev Oncol Hematol. 2005;53:3–11.
Article
PubMed
Google Scholar
Iwasaki Y, Nagata K, Nakanishi M, Natuhara A, Kubota Y, Ueda M, Arimoto T, Hara H. Double-cycle, high-dose ifosfamide, carboplatin, and etoposide followed by peripheral blood stem-cell transplantation for small cell lung cancer. Chest. 2005;128:2268–73.
Article
CAS
PubMed
Google Scholar
Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov. 2005;4:307–20.
Article
CAS
PubMed
Google Scholar
Beck DJ, Brubaker RR. Effect of cis-platinum(II)diamminodichloride on wild type and deoxyribonucleic acid repair deficient mutants of Escherichia coli. J Bacteriol. 1973;116:1247–52.
Fraval HN, Rawlings CJ, Roberts JJ. Increased sensitivity of UV-repair-deficient human cells to DNA bound platinum products which unlike thymine dimers are not recognized by an endonuclease extracted from Micrococcus luteus. Mutat Res. 1978;51:121–32.
Eastman A. The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmac Ther. 1987;34:155–66.
Article
CAS
Google Scholar
Sedletska Y, Giraud-Panis MJ, Malinge JM. Cisplatin is a DNA-damaging antitumour compound triggering multifactorial biochemical responses in cancer cells: importance of apoptotic pathways. Curr Med Chem Anticancer Agents. 2005;5:251–65.
Article
CAS
PubMed
Google Scholar
Fichtinger-Schepman AM, van der Veer JL, den Hartog JH, Lohman PH, Reedijk J. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. Biochemistry. 1985;24:707–13.
Article
CAS
PubMed
Google Scholar
Jamieson ER, Lippard SJ. Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev. 1999;99:2467–98.
Article
CAS
PubMed
Google Scholar
Poklar N, Pilch DS, Lippard SJ, Redding EA, Dunham SU, Breslauer KJ. Influence of cisplatin intrastrand crosslinking on the conformation, thermal stability, and energetics of a 20-mer DNA duplex. Proc Natl Acad Sci. 1996;93:7606-11. PMID: 8755522.
Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, Meyne J, Ratliff RL, Wu JR. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci. 1988;85:6622–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Meyne J, Ratliff RL, Moyzis RK. Conservation of the human telomere sequence (TTAGGG)n among vertebrates. Proc Natl Acad Sci. 1989;86:7049–53.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dong CK, Masutomi K, Hahn WC. Telomerase: regulation, function and transformation. Crit Rev Oncol Hematol. 2005;54:85–93.
Article
PubMed
Google Scholar
Kelland L. Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway. Clin Cancer Res. 2007;13:4960–3.
Article
CAS
PubMed
Google Scholar
Burstyn JN, Heiger-Bernays WJ, Cohen SM, Lippard SJ. Formation of cis-diamminedichloroplatinum(II) 1,2-intrastrand cross-links on DNA is flanking-sequence independent. Nucleic Acids Res. 2000;28:4237–43.
Article
CAS
PubMed
PubMed Central
Google Scholar
Murray V, Kandasamy N. The sequence specificity of the anti-tumour drug, cisplatin, in telomeric DNA sequences compared with consecutive guanine DNA sequences. Anticancer Agents Med Chem. 2012;12:177–81.
Article
CAS
PubMed
Google Scholar
Nguyen HTQ, Galea AM, Murray V. The interaction of cisplatin with a human telomeric DNA sequence containing seventeen tandem repeats. Bioorg Med Chem Lett. 2013;23:1041–5.
Article
CAS
PubMed
Google Scholar
Ishibashi T, Lippard SJ. Telomere loss in cells treated with cisplatin. Proc Natl Acad Sci. 1998;95:4219–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
Unryn BM, Hao D, Glück S, Riabowol KT. Acceleration of telomere loss by chemotherapy is greater in older patients with locally advanced head and neck cancer. Clin Cancer Res. 2006;12:6345–50.
Article
CAS
PubMed
Google Scholar
Markman M, Kennedy A, Webster K, Elson P, Peterson G, Kulp B, Belinson J. Clinical features of hypersensitivity reactions to carboplatin. J Clin Oncol. 1999;17:1141–5.
CAS
PubMed
Google Scholar
Kiernan MC. The pain with platinum: oxaliplatin and neuropathy. Eur J Cancer. 2007;43:2631–3.
Article
CAS
PubMed
Google Scholar
Ding D, Allman BL, Salvi R. Review: Ototoxic characteristics of platinum antitumor drugs. Anatomical Rec. 2012;295:1851–67.
Article
CAS
Google Scholar
Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G. Molecular mechanisms of cisplatin resistance. Oncogenes. 2012;31:1869–83.
Article
CAS
Google Scholar
Apps MG, Johnson BW, Sutcliffe OB, Brown SD, Wheate NJ. Amide coupling reaction for the synthesis of bispyridine-based ligands and their complexation to platinum as dinuclear anticancer agents. J Vis Exp. 2014. doi:10.3791/51740.
PubMed
Google Scholar
Wheate NJ, Collins JG. Multi-nuclear platinum complexes as anti-cancer drugs. Coord Chem Rev. 2003;241:133–45.
Article
CAS
Google Scholar
Farrell NP. Platinum formulations as anticancer drugs clinical and pre-clinical studies. Curr Top Med Chem. 2011;11:2623–31.
Article
CAS
Google Scholar
Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland, LR. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. Clin Cancer Res. 1997;3:2063–74.
CAS
PubMed
Google Scholar
Holford J, Raynaud F, Murrer BA, Grimaldi K, Hartley JA, Abrams M, Kelland LR. Chemical, biochemical and pharmacological activity of the novel sterically hindered platinum co-ordination complex, cis-[amminedichloro(2-methylpyridine)] platinum(II) (AMD473). Anti-Cancer Drug Des. 1998;13:1–18.
CAS
Google Scholar
Munk VP, Diakos CI, Ellis LT, Fenton RR, Messerle BA, Hambley TW. Investigations into the interactions between DNA and conformationally constrained pyridylamine platinum(II) analogues of AMD473. Inorg Chem. 2003;42:3582–90.
Article
CAS
PubMed
Google Scholar
Wheate NJ, Collins JG. Multi-nuclear platinum drugs: A new paradigm in chemotherapy. Curr Med Chem – Anti-Cancer Agents. 2005;5:267–79.
Article
CAS
PubMed
Google Scholar
Hardman LC, Murray V. Use of an automated sequencer to determine the sequence specificity of DNA damage. Biochem Mol Biol Int. 1997;42:349–59.
CAS
PubMed
Google Scholar
Grimaldi KA, McAdam SR, Souhami RL, Hartley JA. DNA damage by anti-cancer agents resolved at the nucleotide level of a single copy gene: evidence for a novel binding site for cisplatin in cells. Nucleic Acids Res. 1994;22:2311–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ponti M, Forrow SM, Souhami RL, D’Incalci M, Hartley JA. Measurement of the sequence specificity of covalent DNA modification by antineoplastic agents using Taq DNA polymerase. Nucleic Acids Res. 1991;19:2929–33.
Murray V, Motyka H, England PR, Wickham G, Lee HH, Denny WA, McFadyen WD. The use of Taq DNA polymerase to determine the sequence specificity of DNA damage caused by cis-diamminedichloroplatinum(II), acridine-tethered platinum(II) diammine complexes or two analogues. J Biol Chem. 1992;267:18805–9.
Murray V. A survey of the sequence-specific interaction of damaging agents with DNA: emphasis on antitumor agents. Prog Nucleic Acids Res Mol Biol. 1999;63:367–415.
Temple MD, McFadyen WD, Holmes RJ, Denny WA, Murray V. Interaction of cisplatin and DNA-targeted 9-aminoacridine platinum complexes with DNA. Biochemistry. 2000;39:5593–9.
Article
CAS
PubMed
Google Scholar
Cairns MJ, Carland M, McFadyen WD, Denny WA, Murray V. The DNA sequence selectivity of maltolato-containing cisplatin analogues in purified plasmid DNA and in intact human cells. J Inorg Biochem. 2009;103:1151–5.
Article
CAS
PubMed
Google Scholar
Paul M, Murray V. Use of an automated capillary DNA sequencer to investigate the interaction of cisplatin with telomeric DNA sequences. Biomed Chromatogr. 2012;26:350–4.
CAS
PubMed
Google Scholar
Deforce DL, Millecamps RE, Van Hoofstat D, Van den Eeckhout EG. Comparison of slab gel electrophoresis and capillary electrophoresis for the detection of the fluorescently labeled polymerase chain reaction products of short tandem repeat fragments. J Chromatogr A. 1998;806:149–55.
Article
CAS
PubMed
Google Scholar
Fundador EV, Choudhary D, Schenkman JB, Rusling JF. Accurate DNA fragment sizing by capillary electrophoresis with laser-induced fluorescence array for detection of sequence specificity of DNA damage. Anal Chem. 2008;80:2212–21.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brabec V, Leng M. DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues. Proc Natl Acad Sci. 1993;90:5345–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brabec V. DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair. Prog Nucleic Acid Res Mol Biol. 2002;71:1–68.
Article
CAS
PubMed
Google Scholar
Schärer OD. DNA interstrand cross-links: natural and drug-induced DNA adducts that induce unique cellular responses. ChemBioChem. 2005;6:27–32.
Article
PubMed
Google Scholar
Noll DM, Mason TM, Miller PS. Formation and repair of interstrand cross-links in DNA. Chem Rev. 2006;106:277–301.
Article
CAS
PubMed
PubMed Central
Google Scholar
Suchánková T, Vojtišková M, Reedijk J, Brabec V, Kašpárková J. DNA and glutathione interactions in cell-free media of asymmetric platinum(II) complexes cis- and trans-[PtCl2(isopropylamine) (1-methylimidazole)]: relations to their different antitumor effects. J Biol Inorg Chem. 2009;14:75–87.
Article
PubMed
Google Scholar
Mlcouskova J, Kasparkova J, Suchankova T, Komeda S, Brabec V. DNA conformation and repair of polymeric natural DNA damaged by antitumor azolato-bridged dinuclear PtII complex. J Inorg Biochem. 2012;114:15–23.
Article
CAS
PubMed
Google Scholar
Hegedüs E, Kókai E, Kotlyar A, Dombrádi V, Szabó G. Separation of 1-23 kb complementary DNA strands by urea-agarose gel electrophoresis. Nucleic Acids Res. 2009. doi:10.1093/nar/gkp539.
PubMed
PubMed Central
Google Scholar
Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJL, Naghavi M. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011;378:1461–84.
Article
PubMed
Google Scholar
Schefter TE, Winter K, Kwon JS, Stuhr K, Balaraj K, Yaremko BP, Small W Jr., Gaffney DK. A phase II study of bevacizumab in combination with definitive radiotherapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma: preliminary results of RTOG 0417. Int J Radiat Oncol Biol Phys. 2012;83:1179–84.
Article
CAS
PubMed
Google Scholar
Olivova R, Stepankova J, Muchova T, Novohradsky V, Novakova O, Vrana O, Kasparkova J, Brabec V. Mechanistic insights into toxic effects of a benzotriazolate-bridged dinuclear platinum(II) compound in tumor cells. Inorg Chim Acta. 2012;393:204–11.
Article
CAS
Google Scholar
Keepers YP, Pizao PE, Peters GJ, van Ark-Otte J, Winograd B, Pinedo HM. Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing. Eur J Cancer. 1991;27:897–900.
Article
CAS
PubMed
Google Scholar
Pope AJ, Bruce C, Kysela B, Hannon MJ. Issues surrounding standard cytotoxicity testing for assessing activity of non-covalent DNA-binding metallo-drugs. Dalton Trans. 2010;39:2772–4.
Article
CAS
PubMed
Google Scholar
Muchova T, Quintal SM, Farrell NP, Brabec V, Kasparkova J. Antitumor bifunctional dinuclear PtII complex BBR3535 forms interduplex DNA cross-links under molecular crowding conditions. J Biol Inorg Chem. 2012;17:239–45.
Article
CAS
PubMed
Google Scholar
Heringova P, Kasparkova J, Brabec V. DNA adducts of antitumor cisplatin preclude telomeric sequences from forming G quadruplexes. J Biol Inorg Chem. 2009;14:959–68.
Article
CAS
PubMed
Google Scholar
Jung YW, Lippard SJ. Direct cellular responses to platinum-induced DNA damage. Chem Rev. 2007;107:1387–407.
Article
CAS
PubMed
Google Scholar
Murray V, Whittaker J, Temple MD, McFadyen WD. Interaction of 11 cisplatin analogues with DNA: characteristic pattern of damage with monofunctional analogues. Biochim Biophys Acta. 1997;1354:261–71.
Article
CAS
PubMed
Google Scholar
Malina J, Farrell NP, Brabec V. DNA condensing effects and sequence selectivity of DNA binding of antitumor noncovalent polynuclear platinum complexes. Inorg Chem. 2014;53:1662–71.
Article
CAS
PubMed
Google Scholar
Kaspárková J, Mellish KJ, Qu Y, Brabec V, Farrell N. Site-specific d(GpG) intrastrand cross-links formed by dinuclear platinum complexes. Bending and NMR studies. Biochemistry. 1996;35:16705–13.
Article
PubMed
Google Scholar
Farrell N, Qu Y, Feng L, Van Houten B. Comparison of chemical reactivity, cytotoxicity, interstrand cross-linking and DNA sequence specificity of bis(platinum) complexes containing monodentate or bidentate coordination spheres with their monomeric analogues. Biochemistry. 1990;29:9522–31.
Article
CAS
PubMed
Google Scholar
Gruff ES, Orgel LE. An efficient, sequence-specific method for cross-linking complementary oligonucleotides using binuclear platinum complexes. Nucleic Acids Res. 1991;19:6849–54.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zou Y, Van Houten B, Farrell N. Sequence specificity of DNA-DNA interstrand cross-link formation by cisplatin and dinuclear platinum complexes. Biochemistry. 1994;33:5404–10.
Article
CAS
PubMed
Google Scholar
Zerzankova L, Kostrhunova H, Vojtiskova M, Novakova O, Suchankova T, Lin M, Guo Z, Kasparkova J, Brabec V. Mechanistic insights into antitumor effects of new dinuclear cis PtII complexes containing aromatic linkers. Biochem Pharmacol. 2010;80:344–51.
Article
CAS
PubMed
Google Scholar
Pracharova J, Novakova O, Kasparkova J, Gibson D, Brabec V. Toxicity in tumor cells, DNA binding mode, and resistance to decomposition by sulfur nucleophiles of new dinuclear bifunctional trans-PtII complexes containing long alkane linkers. Pure Appl Chem. 2013;85:343–54.
CAS
Google Scholar
Zhao Y, Woods JA, Farrer NJ, Robinson KS, Pracharova J, Kasparkova J, Novakova O, Li H, Salassa L, Pizarro AM, Clarkson GJ, Song L, Brabec V, Sadler PJ. Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts. Chem Eur J. 2013;19:9578–91.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wu S, Wang X, Zhu C, Song Y, Wang J, Li Y, Guo Z. Monofunctional platinum complexes containing a 4-nitrobenzo-2-oxa-1,3-diazole fluorophore: Distribution in tumour cells. Dalton Trans. 2011;40:10376–82.
Article
CAS
PubMed
Google Scholar
Gao C, Wang T, Chen J, Zhang Y, Yang B, Gou S. Preparation and in vitro cytotoxicity of oxaliplatin derivatives with chiral amino acids as the carrier group. J Coord Chem. 2014;67:2195–203.
Article
CAS
Google Scholar
Sun Y, Yin R, Gou S, Zhaojian. Antitumor platinum(II) complexes of N-monoalkyl-1R, 2R-diaminocyclohexane derivatives with alkyl groups as hindrance. J Inorg Biochem. 2012;112:68–76.
Article
CAS
PubMed
Google Scholar